Your Article Summary
See Latest ArticlesIdentifying The Potential For Tamoxifen Resistance In Patients
ScienceDaily, 06/26/09
Tamoxifen is a widely used and highly successful drug in the treatment of breast cancer, though resistance to tamoxifen is still a concern in recurrent disease (affecting 25-35% of patients), since therapy resistant metastatic tumor cells are a major cause of death. Researchers have uncovered a protein profile that may accurately predict whether a cancer will be tamoxifen resistant.
Today in Popular Press...keeping you current
Receive free subspecialty "5-minute updates" via email
Three anticoagulant studies may change current medical practice
ScienceDaily, 12/16/09
New Thrombosis Treatments? Blood Clots Form Through Newly Discovered Mechanism
ScienceDaily, 12/16/09
New Technique Detects Proteins That Make Us Age
ScienceDaily, 12/16/09